Hydrogel eye pad for adjuvant therapy of central serous choroidal retinopathy and preparation method of hydrogel eye pad

Abstract

The invention relates to a hydrogel eye pad for adjuvant therapy of central serous choroidal retinopathy. The hydrogel eye pad is mainly prepared from the following raw materials in percentage by weight, 0.01-0.04% of tea essential oil, 0.2-0.8% of tea polyphenol, 0.1-0.6% of theanine, 0.1-0.6%of tea pigment, 0.01-0.04% of jasmine flower essential oil, 0.2-1.0% of safflower extract, 0.2-1.0% of Danshen Extract, 0.2-1.5% of kudzu extract, 0.2-1.5% of dandelion extract, 0.2-1.5% of Celosia argentea extract, 0.2-1.5% of Atractylodes extract, 0.2-1.0% of okra extract, 0.2-1.0% of licorice extract,10-25% of polymer material, 20-30% of glycerol, 0.1-0.5% of citric acid, 1-3% of sorbitol, 0.1-0.3% of aluminum hydroxide, and the balance of purified water. The hydrogel eye pad is an external patch, has the faint scent of jasmine and green tea, can promote absorption of subretinal effusion, shorten the course of disease and improve eyesight, and has the effects of soothing the nerves, resistingwrinkles and the like.

Description

technical field [0001] The invention belongs to the technical field of eye patches, and in particular relates to a hydrogel eye patch for auxiliary treatment of central serous chorioretinopathy and a preparation method thereof. Background technique [0002] Central serous chorioretinopathy (CSC), also known as "CSC", is a common retinal macular lesion, which is caused by damage to the retinal pigment epithelium of the fundus, mainly in the macular area, and spreads to the retinal neuroepithelium of the nearby retina. A lesion characterized by a localized superficial serous detachment. The disease is more common in men aged 20-45, and it is mostly monocular. It is a self-limiting disease. Patients manifested as sudden loss of monocular vision, hazy vision, darkened scenery, smaller vision, and distorted straight lines. Although most patients can recover on their own within 3-6 months, patients who recover on their own are prone to relapse, and after multiple relapses, it ca...

AI Technical Summary

Problems solved by technology

[0005] At present, the treatment methods for CSC mainly include laser photocoagulation, photodynamic therapy (PDT), micropulse laser, transpupil thermotherapy (TTT) and indocyanine green-mediated photoembolization therapy; There are certain limitations and adverse reactions, such as laser photocoagulation can accelerate the absorption of retinal edema, shorten the course of the disease, and reduce the incidence; but it does not target the cause and cannot prevent recurrence

In terms of traditional Chinese medicine treatment, Chinese medicine extraction preparations, compound preparations, empirical prescriptions and other treatment methods are used, and the effect is good. However, Chinese medicine treatment has problems such as long treatment period and inconvenient use.